Literature DB >> 8197166

Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T lymphocytes.

L M Chow1, C Jarvis, Q Hu, S H Nye, F G Gervais, A Veillette, L A Matis.   

Abstract

The activity of Src-related protein-tyrosine kinases is repressed by the phosphorylation of a conserved carboxyl-terminal tyrosine by another cytoplasmic protein-tyrosine kinase termed p50csk. In this study, we characterize Ntk, a protein-tyrosine kinase bearing striking similarities to p50csk. Like p50csk, Ntk possesses Src homology 3 and Src homology 2 domains and lacks the consensus tyrosine phosphorylation and myristoylation sites found in members of the Src family. Expression of ntk transcripts was maximal in brain, and was observed at significant levels in thymus and spleen. ntk RNA levels were dramatically reduced upon mitogenic stimulation of normal T lymphocytes and were minimal in transformed T-cell populations. Firm evidence that Ntk is a Csk-related enzyme was provided by the observation that it phosphorylated a Src-related polypeptide on the inhibitory carboxyl-terminal tyrosine. These findings indicate that Ntk is a Csk-related enzyme that may play an inhibitory role in the control of T-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197166      PMCID: PMC43912          DOI: 10.1073/pnas.91.11.4975

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  [Cecal perforations in the course of acute idiopathic distension of the colon].

Authors:  J M Hay; R Kaswin; F Trémolières; J N Maillard
Journal:  Nouv Presse Med       Date:  1976-01-03

Review 2.  The lymphocyte-specific tyrosine protein kinase p56lck.

Authors:  A Veillette; N Abraham; L Caron; D Davidson
Journal:  Semin Immunol       Date:  1991-05       Impact factor: 11.130

3.  A protein tyrosine kinase involved in regulation of pp60c-src function.

Authors:  M Okada; H Nakagawa
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

4.  Molecular cloning and characterization of the chicken gene homologous to the transforming gene of Rous sarcoma virus.

Authors:  D Shalloway; A D Zelenetz; G M Cooper
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

5.  Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src.

Authors:  S Nada; M Okada; A MacAuley; J A Cooper; H Nakagawa
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

6.  Thymic tumorigenesis induced by overexpression of p56lck.

Authors:  K M Abraham; S D Levin; J D Marth; K A Forbush; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.

Authors:  N Abraham; M C Miceli; J R Parnes; A Veillette
Journal:  Nature       Date:  1991-03-07       Impact factor: 49.962

8.  The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site.

Authors:  F G Gervais; L M Chow; J M Lee; P E Branton; A Veillette
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  12 in total

Review 1.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

2.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.

Authors:  J F Cloutier; A Veillette
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

3.  Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.

Authors:  A Hirao; I Hamaguchi; T Suda; N Yamaguchi
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

4.  Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure.

Authors:  V Joukov; M Vihinen; S Vainikka; J M Sowadski; K Alitalo; M Bergman
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

5.  Evolution of the src-related protein tyrosine kinases.

Authors:  A L Hughes
Journal:  J Mol Evol       Date:  1996-02       Impact factor: 2.395

6.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

7.  Role of the Yes and Csk tyrosine kinases in the development of a pathological state in the human retina.

Authors:  Lyudmila Baranova; Valentina Emelyanova; Igor Volotovski
Journal:  Mol Biol Rep       Date:  2009-09-13       Impact factor: 2.316

8.  Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading.

Authors:  M Bergman; V Joukov; I Virtanen; K Alitalo
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

9.  CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.

Authors:  Anderly C Chüeh; Gahana Advani; Momeneh Foroutan; Jai Smith; Nadia Ng; Harshal Nandurkar; Daisy S Lio; Hong-Jian Zhu; Yuh-Ping Chong; Heather Verkade; Donald J Fujita; Jeffrey Bjorge; Faiza Basheer; Jet Phey Lim; Ian Luk; Amardeep Dhillon; Anuratha Sakthianandeswaren; Dmitri Mouradov; Oliver Sieber; Frédéric Hollande; John M Mariadason; Heung-Chin Cheng
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

10.  CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties.

Authors:  Shudong Zhu; Yan Zhu; Qiuwen Wang; Yi Zhang; Xialing Guo
Journal:  Front Cell Dev Biol       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.